Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Japan Tobacco and Gilead Sciences enter licensing agreement

Dec. 28, 2011

FDA grants new approval for Isentress

Dec. 28, 2011

EMA validates MAA for single-tablet HIV-1 therapy

Dec. 23, 2011

Gilead Sciences submits sNDA for Truvada

Dec. 20, 2011

GeoVax Labs vaccinates first patient in phase I/II AIDS trial

Dec. 16, 2011

New topline data released from elvitegravir trial

Dec. 12, 2011

Pivotal trial of cobicistat meets primary endpoint

Dec. 7, 2011

European Commission approves Edurant for treatment-naive adults with HIV-1

Nov. 29, 2011

Gilead obtains European approval for Eviplera

Nov. 29, 2011

NIH discontinues use of tenofovir gel in HIV prevention study

Nov. 28, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...